|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALLERGAN INC, 10-Q, 2000-11-13 |
Next: TECHNOLOGY FUNDING VENTURE PARTNERS V, 8-K, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-29-2000
<CASH> 378,900
<SECURITIES> 0
<RECEIVABLES> 284,100
<ALLOWANCES> 6,000
<INVENTORY> 121,600
<CURRENT-ASSETS> 905,200
<PP&E> 641,700
<DEPRECIATION> 302,700
<TOTAL-ASSETS> 1,538,800
<CURRENT-LIABILITIES> 413,600
<BONDS> 0
0
0
<COMMON> 1,300
<OTHER-SE> 781,600
<TOTAL-LIABILITY-AND-EQUITY> 1,538,800
<SALES> 381,600
<TOTAL-REVENUES> 396,700
<CGS> 104,600
<TOTAL-COSTS> 118,800
<OTHER-EXPENSES> 47,000
<LOSS-PROVISION> 264
<INTEREST-EXPENSE> 4,500
<INCOME-PRETAX> 75,300
<INCOME-TAX> 20,500
<INCOME-CONTINUING> 54,600
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 54,600
<EPS-BASIC> 0.42
<EPS-DILUTED> 0.41
</TABLE>
|
|